Skegg J L, Anderson S G
Bull World Health Organ. 1969 Apr;40(4):593-600.
The National Institute for Medical Research, London, England, was requested by the WHO Expert Committee on Biological Standardization to arrange a collaborative assay of a serum they had obtained which was suitable to serve as an international reference preparation of anti-staphylococcal P-V leucocidin serum. Seven laboratories in 5 countries assayed a batch of this serum against 4 test preparations. On the basis of the results obtained, the serum has been established as the International Reference Preparation of Anti-Staphylococcal P-V Leucocidin Serum and the International Unit of Anti-Staphylococcal P-V Leucocidin Serum has been defined as the activity contained in 0.3565 mg of the International Standard.
应世界卫生组织生物标准化专家委员会的要求,英国伦敦国家医学研究所安排了一项合作试验,对他们获得的一份血清进行检测,该血清适合用作抗葡萄球菌P-V杀白细胞素血清的国际参考制剂。来自5个国家的7个实验室对一批这种血清与4种试验制剂进行了检测。根据所得结果,该血清已被确立为抗葡萄球菌P-V杀白细胞素血清的国际参考制剂,抗葡萄球菌P-V杀白细胞素血清的国际单位已被定义为0.3565毫克国际标准中所含的活性。